THU0088 Structural Damage Progression in Patients Treated With Methotrexate, Baricitinib Monotherapy or Baricitinib + Methotrexate Based on Their Level of Clinical Response in the Phase 3 Ra-Begin Study

doi 10.1136/annrheumdis-2017-eular.2223
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

SAT0058 Effects of Baricitinib on Patients Who Stop Methotrexate Monotherapy and Switch to Baricitinib Monotherapy

2017English

Long-Term Work Productivity Improvement From Phase 3 Baricitinib Ra-Beam Study: Latin American Subgroup Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Efficacy of Tofacitinib Monotherapy in Methotrexate-Naive Patients With Early or Established Rheumatoid Arthritis

RMD Open
RheumatologyAllergyImmunology
2016English

Mean Cost Per Number Needed to Treat With Tocilizumab Plus Methotrexate Versus Abatacept Plus Methotrexate in the Treatment of Rheumatoid Arthritis in Patients Previously Treated With Methotrexate

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2017English

Improvements in Clinical Response Between 12 and 24 Weeks in Patients With Rheumatoid Arthritis on Etanercept Therapy With or Without Methotrexate

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2008English

Pms5 - A Network Meta-Analysis to Evaluate the Efficacy of Baricitinib and Other Treatments of Rheumatoid Arthritis in Patients Who Are Inadequate Responders to Methotrexate

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Letter: Addition of Methotrexate Neither Restores Clinical Response Nor Improves the Pharmacokinetic Profile of Vedolizumab-Treated Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic and Safety Outcomes From the 24-Month Phase 3 ORAL Scan Study

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2019English

Achieving Comprehensive Disease Control in Patients With Early and Established Rheumatoid Arthritis Treated With Adalimumab Plus Methotrexate Versus Methotrexate Alone

RMD Open
RheumatologyAllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy